Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in AXGN — Axogen, Inc.

CIK 861177 NEW YORK, NY
Back to AXGN Full portfolio

Position in AXGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,673,212
+$1,659,903 QoQ
Shares Held
79,524
+30.9% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 253 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 48% Shared 0% None 52%

Common Shares in AXGN Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,748,157,927 across 62 Medical Devices names. AXGN ranks #24 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 12,835,753 $1,164,716,222
2 SYK
Stryker Corp
 2,689,376 $846,723,135
3 DXCM
Dexcom Inc
 11,261,876 $758,487,343
4 BSX
Boston Scientific Corp
 13,091,481 $558,744,402
5 EW
Edwards Lifesciences Corp
 5,488,643 $496,502,640
6 GEHC
GE HealthCare Technologies Inc.
 2,541,393 $162,674,562
7 ZBH
Zimmer Biomet Holdings, Inc.
 1,457,553 $125,480,733
8 BIO
Bio-Rad Laboratories, Inc.
 418,884 $122,988,525

All Filings in AXGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,673,212 79,524
2026-03-31 $2,013,309 60,770
2025-12-31 $1,971,982 60,250
2025-09-30 $980,218 54,945
2025-06-30 $1,219,332 112,381
2025-03-31 $767,934 41,510
2023-09-30 $52,690 10,538
2022-12-31 $213,472 21,390
2022-03-31 $323,481 40,741
2021-12-31 $381,740 40,741
2021-09-30 $643,707 40,741
2021-06-30 $880,410 40,741
2021-03-31 $828,794 40,908
2020-12-31 $716,357 40,020
2020-09-30 $538,491 46,302
2020-06-30 $365,247 39,529
2020-03-31 $422,822 40,656